✨ SAVE 10% WITH CODE: WELCOME10 • FREE GHK-CU 100MG ON ORDERS $300+

⚠️ FOR LABORATORY & RESEARCH USE ONLY — NOT FOR HUMAN OR VETERINARY USE

TB-500 – 5mg

$41.17

Availability: 463 in stock (can be backordered)

Vial Quantity Discounts

Quantity Price / Vial Savings
1-2 vials — —
3-4 vials — 10% off
5-9 vials — 15% off

TB-500 (Thymosin Beta-4 Acetate) – 5mg

CAS Number: 77591-33-4
Molecular Formula: C212H350N56O78S
Molecular Weight: 4963.49 g/mol
Synonyms: Thymosin Beta-4, Tβ4, TB500

Description:
TB-500 is a synthetic version of a naturally occurring peptide known as Thymosin Beta-4. It is widely studied in research environments for its role in actin binding and regulation, cellular migration, and tissue recovery processes. In vitro studies often focus on TB-500’s interactions with cell motility and cytoskeletal dynamics, particularly in models of wound healing, angiogenesis, and inflammation modulation.

Form: Lyophilized powder
Purity: ≥98% (HPLC)
Storage: Store at -20°C. Protect from light and moisture.
Solubility: Soluble in sterile water, DMSO, or appropriate buffer.

Applications:
For laboratory research use only. Not for human consumption, diagnostic, or therapeutic purposes.

Disclaimer:
All products sold by SP Biolabs are intended for laboratory research use only. Not for human or veterinary use. Not for diagnostic, therapeutic, or cosmetic purposes. By purchasing, you confirm that you are a qualified professional or entity using these materials for lawful scientific research only.

🔬 MOLECULAR PROFILE

What Is TB-500 - 5mg?

TypeSynthetic peptide
CAS Number885340-08-9
Molecular Weight889.02 g/mol (free base)
Amino Acids7 amino acids (Heptapeptide)
🔗 PubChem Database
🧊 STORAGE REQUIREMENTS

Stability Information

Avoid freeze/thaw cycles Protect from light Keep refrigerated Keep frozen
❄️
Lyophilized (powder)
-20°C (preferred) · 24–36 months
💧
Reconstituted
2–8°C

📚 Sources & References

Peer-reviewed research

DRUG TESTING AND ANALYSIS
Synthesis and characterization of the N-terminal acetylated 17–23 fragment of thymosin β4 identified in TB-500
2012 · Esposito S., Deventer K., Goeman J., et al.
View Source ↗
FDA GSRS
TB-500 (N-Acetyl-Leu-Lys-Lys-Thr-Glu-Thr-Gln)
2026 · National Center for Advancing Translational Sciences
View Source ↗

Certificate of Analysis

Scroll to Top